Topics

. @TakedaPharma Licenses @CourPharma’s #CeliacDisease Candidate after Successful Phase IIa Trial: http://ow.ly/L3fd50wRsfN pic.twitter.com/QrghrKTmkK

14:25 EDT 26 Oct 2019 | Genetic Engineering News

. Licenses ’s Candidate after Successful Phase IIa Trial: http://ow.ly/L3fd50wRsfN 

Original Article: . @TakedaPharma Licenses @CourPharma’s #CeliacDisease Candidate after Successful Phase IIa Trial: http://ow.ly/L3fd50wRsfN pic.twitter.com/QrghrKTmkK

NEXT ARTICLE

More From BioPortfolio on ". @TakedaPharma Licenses @CourPharma’s #CeliacDisease Candidate after Successful Phase IIa Trial: http://ow.ly/L3fd50wRsfN pic.twitter.com/QrghrKTmkK"

Quick Search